Stocks analysis

Analysis for CPB

  • 📈 Growth — 8/30
  • 💰 Profitability — 14/20
  • 🏦 Financial Health — 11/20
  • 💵 Valuation — 12/20
  • ⚠️ Risk — 6/10
Overall Score: 49/100

Summary:


📈 Growth & Financial Trajectory

The 8-quarter window shows revenue oscillation between roughly $2.32B and $2.68B with an overall flat trajectory. Starting at about $2.37B in 2024-Q3 and ending near $2.37B in 2026-Q3, the top line shows little long-term growth. Net income declined from about $133M to $124M, with a notable quarterly spike to $194M in 2026-Q1, suggesting episodic effects rather than sustained improvement.

💰 Margins & Cash Flow

Gross margin runs in the high 20s (roughly 28%–30%). Operating margin sits around 10%–12%, indicating stable profitability but modest operating leverage. Net cash flow from operating activities was positive in most quarters; cash outflows from investing/financing caused a quarterly net cash flow of about −$159M in 2026-Q3.

🛡️ Balance Sheet & Liquidity

Assets around $15.1B, with current assets near $2.56B and current liabilities near $2.95B (current ratio ~0.87). Total liabilities ~$11.11B vs. equity ~$4.03B. Leverage is meaningful but typical for a consumer staples company; liquidity is modest but supported by steady operating cash flow.

⚠️ Key Drivers & Risks

  • Drivers: Brand strength in soups/ready-to-eat, and disciplined cost/mix management.
  • Risks: Consumer cyclicality and input cost volatility; valuation sensitivity to earnings fluctuations.